NXTS Latest Press Releases

-- June 29, 2026 --

Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation - Significant Premium to Initial Investment Globe Newswire 8:20 AM

-- June 22, 2026 --

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery Globe Newswire 8:22 AM

-- June 17, 2026 --

Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases Globe Newswire 7:32 AM

-- May 18, 2026 --

Nexentis Announces MitoCareX Bio Achieves Key R&D Milestone, Generating a Substantially Improved Hit Molecule on the Path to Pre-Clinical Development Globe Newswire 9:30 AM

-- May 13, 2026 --

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone Globe Newswire 7:07 AM

-- May 5, 2026 --

Nexentis Technologies Announces U.S. Trademark Registration Approval for MitoCareX's Algorithm Platform MITOLINE Globe Newswire 7:32 AM

-- March 13, 2026 --

Nexentis Technologies Inc. Launches New Corporate Website, Showcasing Innovative AI-Driven Biotech Platform Globe Newswire 9:15 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software